Search for: "Barr Laboratories IncĀ " Results 101 - 120 of 166
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2010, 11:22 am by Beck, et al.
Barr Laboratories, Inc., 2009 WL 4047949 (N.D. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) EU: ‘Victory’ against biopiracy - EPO revokes Schwabe Pharmaceuticals' pelargonium extract patent (Spicy IP) (IP Watch)   General Another case for indigenous knowledge protection, but how? [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly (EPLAW) Indian… [read post]
14 Jan 2010, 11:08 pm by Dr. Shezad Malik
A dozen companies that sold the drugs are named in the Arkansas suits, including Pfizer Inc. and Wyeth Pharmaceuticals Inc., Barr Laboratories Inc. and Mead Johnson & Co., among others. [read post]
31 Dec 2009, 7:25 am
Court of Appeals in New York City, considering an action challenging a settlement agreement between drug maker Bayer AG and the generic defendant Barr Laboratories, Inc. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Barr Pharmaceuticals, Inc., Barr Pharmaceuticals, LLC and Barr Laboratories Inc. [read post]
25 Nov 2009, 9:07 am
Ocella is the generic equivalent of Yasmin, manufactured by Barr Laboratories. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of… [read post]
11 Oct 2009, 9:04 pm
.; Barr Laboratories Inc.; Barr Pharmaceuticals Inc.; Barr Pharmaceuticals, LLC; Teva Pharmaceuticals Industries Ltd.; Teva Pharmaceuticals USA Inc. [read post]
9 Oct 2009, 9:11 am
PLIVA-HRVATSKA d.o.o, PLIVA d.d., Barr Laboratories Inc., Barr Pharmaceuticals Inc., Barr Pharmaceuticals, LLC, et al. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
27 Sep 2009, 2:30 pm
As we noted in Genentech, Inc. v. [read post]
23 Sep 2009, 12:45 am
Some cases of botulism may go undiagnosed because symptoms are transient or mild, or are misdiagnosed as Guillain-Barre Syndrome. [read post]
26 Aug 2009, 9:20 am
Barr Labs., Inc., No. 2008-1282, 2009 U.S. [read post]
24 Aug 2009, 10:29 pm
Our office is investigating claims of injury related to the birth control pills known as Yaz or Yasmin:Yasmin and Yaz are two types of birth control pills manufactured by Bayer Healthcare, and the generic, Ocella, is marketed and distributed by Barr Laboratories, Inc. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]